Macarena de la Fuente
@delaFuenteNOnc
Followers
406
Following
1K
Media
6
Statuses
192
Mom. Chief, Neuro-oncology Division @SylvesterCancer
Joined December 2019
RT @NBTStweets: TODAY is our Head to the Hill Day of Action!. Take 2 minutes to sign our action alert — it urges your members of Congress t….
0
7
0
🧠 Ready to advance your LGG care strategy?.Gain expert insights on selecting the right patients for targeted therapy & how to apply it across your clinical team. 🌟 Don’t miss this! Register now: 👥 @MichaelLimMD, @delaFuenteNOnc, and Mitchel S. Berger,
0
0
4
RT @MedscapeLIVE: 🧠 Ready to advance your LGG care strategy?.Gain expert insights on selecting the right patients for targeted therapy & ho….
0
1
0
Sharing this new trial led by @AshishHShah4 Very innovative approach for patients with ND unresectable GBM who often are not eligible for clinical trials. Now enrolling at @SylvesterCancer @UMiamiNeuro.
Thrilled that we are enrolling for STARLITE phase 1 trial for newly diag. unresectable GBM. We will combine FDA-approved antiretroviral drugs +Laser ablation+SOC. The trial leverages the anticancer effects of ART to target treatment resistant GBM stem cell niche. NCT06428045
0
0
5
RT @to_be_elizabeth: 📌 Incorporating Targeted Therapy Into Neuro-Oncology Practice.👉🏻 This review presents a compre….
0
12
0
RT @GCAResearch: Dr. @J_deGrootMD, Chief of Neuro-Oncology at @UCSF, Arm Co-PI of VAL-083 and GBM AGILE Arm Selection Committee Member pres….
0
7
0
RT @GCAResearch: GBM AGILE leadership gathering at #ASCO24 .Trial leadership joined together to plan new trial innovations, advance excitin….
0
6
0
Join us tomorrow @ASCO #ASCO24 #btsm.All what you need to know about IDHm gliomas with Drs. Wen, Preusser and @DrFlorienBoele .@SylvesterCancer @NeuroOnc
1
7
19
Thanks @SylvesterCancer for the commitment and support. We aim for more effective and less toxic treatments for brain tumor patients. @UMiamiNeuro @UMiamiHealth.
We're excited to announce the formation of the Sylvester Brain Tumor Institute (SBTI), which will elevate #cancer care and #research in #SouthFL and beyond. Our leadership team is dedicated to creating personalized treatments for each patient. 🙌 . Learn more:
0
2
19
Join us at #ASCO24 to hear all about IDHm glioma therapies! @SylvesterCancer @UMiamiNeuro @DrFlorienBoele.
💡 Explore the latest in IDH-mutant glioma therapies at #ASCO24! Gain insights on who benefits most and enhance your treatment strategies with cutting-edge data. Boost your clinical confidence! 🧠 @delaFuenteNOnc .@DrFlorienBoele
0
1
11
After a decade of work at @SylvesterCancer, I am so proud and excited to join forces with so many physicians, scientists and collaborators to accelerate discoveries and translate them to the clinic to benefit brain tumor patients. @UMiamiNeuro @NeuroOnc.
🧠🙌 We're proud to introduce the Sylvester Brain Tumor Institute (SBTI), aiming to personalize #BrainCancer treatment with a team science approach. Learn how our team will help enhance the lives of brain tumor patients: #BTAM #CancerResearch
4
3
39
RT @AshishHShah4: Excited to say that we are enrolling recurrent high-grade gliomas for a novel biomarker driven retroviral gene therapy tr….
0
8
0
RT @NeuroOnc: 📣Last day to apply for the SNO and Oxford University Press Editorial Scholar’s Program. This opportunity is offered to early….
0
2
0
RT @Latinamd: March is #NationalSocialWorkMonth 💪🏽and today I want to acknowledge @SylvesterCancer social workers like Lisset Robertson wh….
0
4
0
🗳️ Vote TODAY for @GoHealio @HemOncToday's #HealioInnovators awards presented at #ASCO24 including some amazing @SylvesterCancer investigators and collaborators:. @sophiahlge - Woman Disruptor.@delaFuenteNOnc -Health Equity.@DrRobWinn - Lifetime Disruptor.@OncBrothers.
0
0
3
Looking forward to this talk. Dr. Tim Cloughesy on “Emerging Role of IDH inhibitors in IDH mutant Glioma”. @SylvesterCancer @UMiamiNeuro.
Excited to continue the Ralph L. Sacco Resident Research Day. Look forward to wonderful presentations and thank you to our guest speaker Dr. Cloughesy. @MiamiNeuroRes @Umiamihealth @Umiamimedicine
0
1
8
0
0
16
RT @NeuroOnc: SNO and Oxford University Press are pleased to announce the Editorial Scholar’s Program. This opportunity is offered to early….
0
4
0
